Globally, South Africa is amongst the countries with the highest tuberculosis (TB) burden and high statistics of people living with HIV. Two of the biggest issues in reducing both these numbers are access and adherence to medication, but this can change with a new TB treatment.
South Africa’s long-standing position as a country with high numbers of TB infections continues to worry, especially in light of Covid-19’s spread — but the country has some of the world’s top TB researchers, say experts.
At 13, most boys dream of becoming football stars, musicians or famous actors but Thabo Pelesane discovered that he had pulmonary tuberculosis (TB) in 1989 while he was still at Itirele Primary School in Jouberton near Klerksdorp.
While the almost 70% price reduction in important tuberculosis prevention drug Rifapentine for 100 countries with significant TB epidemics is a breakthrough, the high cost of newer drugs remains a barrier.
Civil society groups have criticised the United Nations declaration on tuberculosis (TB) ratified yesterday (26 Sept) saying it ‘falls short’ on critical issues in the fight against the world’s top infectious killer.
Brazil, Russia, India, China and South Africa account for half of the world’s tuberculosis cases, but only South Africa’s president will attend today’s (September 26th) first United Nations high-level meeting on TB.